Related Experiment Video
Updated: Aug 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Nadia Ghasemi Darestani1, Anna I Gilmanova2, Moaed E Al-Gazally3
1Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:
Oncolytic viruses (OVs) infect, multiply, and finally remove tumor cells selectively, causing no damage to normal cells in the process. Because of their specific features, such as, the ability to induce immunogenic cell death and to contain curative transgenes in their genomes, OVs have attracted attention as candidates to be utilized in cooperation with immunotherapies for cancer treatment. This treatment takes advantage of most tumor cells' inherent tendency to be infected by certain OVs and both innate and adaptive immune responses are elicited by OV infection and oncolysis. OVs can also modulate tumor microenvironment and boost anti-tumor immune responses. Mesenchymal stem cells (MSC) are gathering interest as promising anti-cancer treatments with the ability to address a wide range of cancers. MSCs exhibit tumor-trophic migration characteristics, allowing them to be used as delivery vehicles for successful, targeted treatment of isolated tumors and metastatic malignancies. Preclinical and clinical research were reviewed in this study to discuss using MSC-released OVs as a novel method for the treatment of cancer. Video Abstract.
Insights
Oncolytic viruses (OVs) selectively destroy tumor cells and can be enhanced with immunotherapy. Mesenchymal stem cells (MSCs) show promise as delivery vehicles for OV cancer therapy.
Area of Science:
- Oncolytic virotherapy
- Cancer immunotherapy
- Stem cell biology
Background:
- Oncolytic viruses (OVs) selectively target and eliminate tumor cells while sparing normal tissues.
- OVs possess unique properties, including inducing immunogenic cell death and carrying therapeutic transgenes, making them valuable for cancer treatment.
- OVs can stimulate both innate and adaptive immune responses and modify the tumor microenvironment to enhance anti-tumor immunity.
Discussion:
- Mesenchymal stem cells (MSCs) are being investigated for their potential in treating various cancers.
- MSCs possess tumor-homing capabilities, enabling them to serve as effective delivery systems for targeted cancer therapies.
- This review examines preclinical and clinical research on utilizing MSC-released OVs for novel cancer treatment strategies.
Key Insights:
- OVs offer a targeted approach to cancer treatment by selectively infecting and lysing tumor cells.
- The combination of OVs with immunotherapy holds significant promise for improving cancer treatment outcomes.
- MSCs can be engineered as delivery vehicles to enhance the efficacy and targeting of OV-based cancer therapies.
Outlook:
- Further research into MSC-OV combinations could lead to innovative therapeutic strategies for challenging cancers.
- Clinical translation of MSC-delivered OVs may offer new hope for patients with isolated tumors and metastatic disease.
- Optimizing MSC-mediated delivery systems will be crucial for maximizing the therapeutic potential of oncolytic virotherapy.
Related Concept Videos
Mesenchymal Stem Cells
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

